Published Research

2008-2007

2008-2007

The role of tree nuts and peanuts in the prevention of coronary heart disease: multiple potential mechanisms.*

Relative validity of a food frequency questionnaire used to assess food intake during a dietary intervention study.

Suppression of implanted MDA-MB 231 human breast cancer growth in nude mice by dietary walnut.

The effect of walnut intake on factors related to prostate and vascular health in older men.

Lack of effect of walnuts on serum levels of prostate specific antigen: a brief report.

An increase in dietary n-3 fatty acids decreases a marker of bone resorption in humans.

Dietary alpha-linolenic acid inhibits proinflammatory cytokine production by peripheral blood mononuclear cells in hypercholesterolemic subjects.

The role of tree nuts and peanuts in the prevention of coronary heart disease: multiple potential mechanisms.*

Kris-Etherton PM, Hu FB, Ros E, Sabaté J. The role of tree nuts and peanuts in the prevention of coronary heart disease: multiple potential mechanisms. J Nutr. 2008 Sep;138(9):1746S-1751S.

Epidemiologic and clinical trial evidence has demonstrated consistent benefits of nut and peanut consumption on coronary heart disease (CHD) risk and associated risk factors. The epidemiologic studies have reported various endpoints, including fatal CHD, total CHD death, total CHD, and nonfatal myocardial infarct. A pooled analysis of 4 U.S. epidemiologic studies showed that subjects in the highest intake group for nut consumption had an approximately 35% reduced risk of CHD incidence. The reduction in total CHD death was due primarily to a decrease in sudden cardiac death. Clinical studies have evaluated the effects of many different nuts and peanuts on lipids, lipoproteins, and various CHD risk factors, including oxidation, inflammation, and vascular reactivity. Evidence from these studies consistently shows a beneficial effect on these CHD risk factors. The LDL cholesterol-lowering response of nut and peanut studies is greater than expected on the basis of blood cholesterol-lowering equations that are derived from changes in the fatty acid profile of the diet. Thus, in addition to a favorable fatty acid profile, nuts and peanuts contain other bioactive compounds that explain their multiple cardiovascular benefits. Other macronutrients include plant protein and fiber; micronutrients including potassium, calcium, magnesium, and tocopherols; and phytochemicals such as phytosterols, phenolic compounds, resveratrol, and arginine. Nuts and peanuts are food sources that are a composite of numerous cardioprotective nutrients and if routinely incorporated in a healthy diet, population risk of CHD would therefore be expected to decrease markedly.

Full text available: http://jn.nutrition.org/content/138/9/1746S.long


Relative validity of a food frequency questionnaire used to assess food intake during a dietary intervention study.

Segovia-Siapco G, Singh P, Haddad E, Sabaté J. Relative validity of a food frequency questionnaire used to assess food intake during a dietary intervention study. Nutr Cancer. 2008;60(5):603-11.

To develop a cost-effective alternative for evaluating dietary intake in large-scale intervention trials of cancer and cardiovascular disease outcomes, we designed and validated a semiquantitative food frequency questionnaire (FFQ). We collected 6 to 8 of the 24-hr dietary recalls from 87 adults (ages 30-72 yr) who were randomly assigned to a walnut-supplemented diet or a control diet in a 6-mo dietary intervention trial. Relative validity of a 171-item FFQ in assessing intake of selected foods and the prescribed intervention (intake > or =25 g/day or intake < 2 g of walnuts) was determined using 24-h dietary recalls as the reference. De-attenuated correlations between FFQ and dietary recalls were .82 for walnuts, .80 for fruits, .79 for grains, .77 for vegetables, .63 for water, .44 for sweets, and .36 for dairy/eggs. High within-person variation did not allow de-attenuation for the remaining foods, but uncorrected correlations were high (> .7) for the beverage variables. The FFQ correctly classified 86 out of 87 subjects in the 2 prescribed intervention groups. The FFQ can provide an accurate measure of a food-based intervention (i.e., walnut supplementation) in a trial setting and can also accurately estimate a number of other food groups consumed during the trial.

Full text available for purchase: http://www.tandfonline.com/doi/abs/10.1080/01635580802065294?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed


Suppression of implanted MDA-MB 231 human breast cancer growth in nude mice by dietary walnut.

Hardman WE, Ion G. Suppression of implanted MDA-MB 231 human breast cancer growth in nude mice by dietary walnut. Nutr Cancer. 2008;60(5):666-74.

Walnuts contain components that may slow cancer growth including omega 3 fatty acids, phytosterols, polyphenols, carotenoids, and melatonin. A pilot study was performed to determine whether consumption of walnuts could affect growth of MDA-MB 231 human breast cancers implanted into nude mice. Tumor cells were injected into nude mice that were consuming an AIN-76A diet slightly modified to contain 10% corn oil. After the tumors reached 3 to 5 mm diameter, the diet of one group of mice was changed to include ground walnuts, equivalent to 56 g (2 oz) per day in humans. The tumor growth rate from Day 10, when tumor sizes began to diverge, until the end of the study of the group that consumed walnuts (2.9 +/- 1.1 mm(3)/day; mean +/- standard error of the mean) was significantly less (P > 0.05, t-test of the growth rates) than that of the group that did not consume walnuts (14.6 +/- 1.3 mm(3)/day). The eicosapentaenoic and docosahexaenoic acid fractions of the livers of the group that consumed walnuts were significantly higher than that of the group that did not consume walnuts. Tumor cell proliferation was decreased, but apoptosis was not altered due to walnut consumption. Further work is merited to investigate applications to cancer in humans.

Full text available for purchase: http://www.tandfonline.com/doi/abs/10.1080/01635580802065302?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed


The effect of walnut intake on factors related to prostate and vascular health in older men.

Spaccarotella KJ, Kris-Etherton PM, Stone, WL, Bagshaw, DM, Fishell VK, West SG, Lawrence FR, and Hartman TJ. The effect of walnut intake on factors related to prostate and vascular health in older men. Nutr J. 2008 May 2;7:13.

BACKGROUND: Tocopherols may protect against prostate cancer and cardiovascular disease (CVD).

METHODS: We assessed the effect of walnuts, which are rich in tocopherols, on markers of prostate and vascular health in men at risk for prostate cancer. We conducted an 8-week walnut supplement study to examine effects of walnuts on serum tocopherols and prostate specific antigen (PSA). Subjects (n = 21) consumed (in random order) their usual diet +/- a walnut supplement (75 g/d) that was isocalorically incorporated in their habitual diets. Prior to the supplement study, 5 fasted subjects participated in an acute time course experiment and had blood taken at baseline and 1, 2, 4, and 8 h after consuming walnuts (75 g).

RESULTS: During the time course experiment, triglycerides peaked at 4 h, and gamma-tocopherol (gamma-T) increased from 4 to 8 h. Triglyceride - normalized gamma-T was two-fold higher (P = 0.01) after 8 versus 4 h. In the supplement study, change from baseline was +0.83 +/- 0.52 micromol/L for gamma-T, -2.65 +/- 1.30 micromol/L for alpha-tocopherol (alpha-T) and -3.49 +/- 1.99 for the tocopherol ratio (alpha-T: gamma-T). A linear mixed model showed that, although PSA did not change, the ratio of free PSA:total PSA increased and approached significance (P = 0.07). The alpha-T: gamma-T ratio decreased significantly (P = 0.01), partly reflecting an increase in serum gamma-T, which approached significance (P = 0.08).

CONCLUSION: The significant decrease in the alpha-T: gamma-T ratio with an increase in serum gamma-T and a trend towards an increase in the ratio of free PSA:total PSA following the 8-week supplement study suggest that walnuts may improve biomarkers of prostate and vascular status.

Full text available: http://www.nutritionj.com/content/7/1/13


Lack of effect of walnuts on serum levels of prostate specific antigen: a brief report.

Simon J, Sabaté J, Tanzman J. Lack of effect of walnuts on serum levels of prostate specific antigen: a brief report. J Am Coll Nutr. 2007; 26; 4; 317-320.

OBJECTIVE: To examine whether the short-term consumption of walnuts, a food rich in alpha-linolenic acid, affects levels of serum prostate-specific antigen (PSA), a marker of prostate enlargement, inflammation, and cancer.

METHODS: Using data from a 12-month randomized crossover study examining the effect of walnut consumption on body composition, we examined whether increased walnut consumption (mean 35 grams daily, 12% total energy) affected serum PSA levels among 40 middle-aged men.

RESULTS: There was no significant difference between mean PSA level at the conclusion of the 6-month walnut-supplemented diet (1.05 mug/L, 95% CI [0.81, 1.37]) and the conclusion of the 6-month control diet (1.06 mug/L, 95% CI [0.81, 1.38]) (P = 0.86) (or a mean proportional decrease in PSA of -1%).

CONCLUSIONS: Our results suggest that short-term consumption of walnuts is unlikely to affect PSA levels adversely among otherwise normal men.

Full text available: http://www.jacn.org/content/26/4/317.full.pdf+html


An increase in dietary n-3 fatty acids decreases a marker of bone resorption in humans.

Griel AE, Kris-Etherton PM, Hilpert KF, Zhao G, West SG, Corwin RL. An increase in dietary n-3 fatty acids decreases a marker of bone resorption in humans. Nutr J. 2007 Jan 16;6:2.

Human, animal, and in vitro research indicates a beneficial effect of appropriate amounts of omega-3 (n-3) polyunsaturated fatty acids (PUFA) on bone health. This is the first controlled feeding study in humans to evaluate the effect of dietary plant-derived n-3 PUFA on bone turnover, assessed by serum concentrations of N-telopeptides (NTx) and bone-specific alkaline phosphatase (BSAP). Subjects (n = 23) consumed each diet for 6 weeks in a randomized, 3-period crossover design: 1) Average American Diet (AAD; [34% total fat, 13% saturated fatty acids (SFA), 13% monounsaturated fatty acids (MUFA), 9% PUFA (7.7% LA, 0.8% ALA)]), 2) Linoleic Acid Diet (LA; [37% total fat, 9% SFA, 12% MUFA, 16% PUFA (12.6% LA, 3.6% ALA)]), and 3) alpha-Linolenic Acid Diet (ALA; [38% total fat, 8% SFA, 12% MUFA, 17% PUFA (10.5% LA, 6.5% ALA)]). Walnuts and flaxseed oil were the predominant sources of ALA. NTx levels were significantly lower following the ALA diet (13.20 +/- 1.21 nM BCE), relative to the AAD (15.59 +/- 1.21 nM BCE) (p < 0.05). Mean NTx level following the LA diet was 13.80 +/- 1.21 nM BCE. There was no change in levels of BSAP across the three diets. Concentrations of NTx were positively correlated with the pro-inflammatory cytokine TNFalpha for all three diets. The results indicate that plant sources of dietary n-3 PUFA may have a protective effect on bone metabolism via a decrease in bone resorption in the presence of consistent levels of bone formation.

Full text available: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1784104/?tool=pubmed


Dietary alpha-linolenic acid inhibits proinflammatory cytokine production by peripheral blood mononuclear cells in hypercholesterolemic subjects.

Zhao G, Etherton TD, Martin KR, Gillies PJ, West SG, Kris-Etherton PM. Dietary alpha-linolenic acid inhibits proinflammatory cytokine production by peripheral blood mononuclear cells in hypercholesterolemic subjects. Am J Clin Nutr. 2007; 85:385-91.

BACKGROUND: Atherosclerosis is a chronic inflammatory disease. We previously reported that a diet high in alpha-linolenic acid (ALA) reduces lipid and inflammatory cardiovascular disease risk factors in hypercholesterolemic subjects.

OBJECTIVE: The objective was to evaluate the effects of a diet high in ALA on serum proinflammatory cytokine concentrations and cytokine production by cultured peripheral blood mononuclear cells (PBMCs) from subjects fed the experimental diets.

DESIGN: A randomized, controlled, 3-diet, 3-period crossover study design was used. Hypercholesterolemic subjects (n = 23) were assigned to 3 experimental diets: a diet high in ALA (ALA diet; 6.5% of energy), a diet high in linoleic acid (LA diet; 12.6% of energy), and an average American diet (AAD) for 6 wk. Serum interleukin (IL)-6, IL-1beta, and tumor necrosis factor-alpha (TNF-alpha) concentrations and the production of IL-6, IL-1beta, and TNF-alpha by PBMCs were measured.

RESULTS: IL-6, IL-1beta, and TNF-alpha production by PBMCs and serum TNF-alpha concentrations were lower (P < 0.05 and P < 0.08, respectively) with the ALA diet than with the LA diet or AAD. PBMC production of TNF-alpha was inversely correlated with ALA (r = -0.402, P = 0.07) and with eicosapentaenoic acid (r = -0.476, P = 0.03) concentrations in PBMC lipids with the ALA diet. Changes in serum ALA were inversely correlated with changes in TNF-alpha produced by PBMCs (r = -0.423, P < 0.05).

CONCLUSIONS: Increased intakes of dietary ALA elicit antiinflammatory effects by inhibiting IL-6, IL-1beta, and TNF-alpha production in cultured PBMCs. Changes in PBMC ALA and eicosapentaenoic acid (derived from dietary ALA) are associated with beneficial changes in TNF-alpha release. Thus, the cardioprotective effects of ALA are mediated in part by a reduction in the production of inflammatory cytokines.

Full text available: http://www.ajcn.org/content/85/2/385.full.pdf+html


* Paper funded by The International Tree Nut Council Nutrition Research & Education Foundation of which the California Walnut Commission is a member and provides financial support.

** Paper is of relevance but not specifically funded by the California Walnut Commission

All abstracts from http://www.ncbi.nlm.nih.gov/pubmed